The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Veerisa VimolchalaoSiwat SakdejayontPloytuangporn WongchanapaiShama SukprakunPattama AngspattWilai ThawinwisanPiyachut ChenaksaraVirote SriuranpongChanida VinayanuwatikunNapa ParinyanitikunNattaya PoovorawanSuebpong Tanasanvimon

Published in: International journal of clinical oncology (2019)

The addition of olanzapine to ondansetron and dexamethasone significantly improved CINV prevention and was safe in patients receiving HEC.

Keyphrases

chemotherapy induced
high dose
low dose
squamous cell carcinoma
radiation therapy
locally advanced